Ausgabe 2/2020
Inhalt (25 Artikel)
Circumnavigating the challenges of COVID-19 in oncology
Thorsten Fuereder, Eberhard Gunsilius, Rupert Bartsch, Wolfgang Hilbe
ESMO 2019—personal non-small lung cancer highlights
Lena Horvath, Andreas Pircher
The role of surgery in soft tissue sarcoma: Can we improve outcome and function towards sporting activities?
Reinhard Windhager, Gerhard M. Hobusch
Metastatic sarcoma: tailored strategies for a heterogeneous disease
Massimiliano Grassi, Andrea Spagnoletti, Alberto Puccini
Screening for ovarian cancer: is there still hope?
Stefanie Aust, Veronika Seebacher-Shariat
Ovarian cancer surgery
Richard Schwameis, Valentina Paspalj, Marlene Kranawetter, Stephan Polterauer
PARP inhibitors in the treatment of ovarian cancer
Alain G. Zeimet, Verena Wieser, Katharina Knoll, Daniel Reimer, Christian Marth
Current state and perspectives of checkpoint inhibitors in ovarian cancer treatment
Thomas Bartl, Valentina Paspalj, Stephan Polterauer, Christoph Grimm
Thermal ablation—an option in curative treatment of HCC
Daniel Putzer, Peter Schullian, Gernot Eberle, Reto Josef Bale
The intestinal microbiota and hepatocellular carcinoma
Maria Effenberger, Herbert Tilg
PLATON: use of romiplostim to treat chronic primary immune thrombocytopenia
Georgi Mihaylov, Barbara Skopec, Zuzana Sninska, Nikolai Tzvetkov, Olga Cerna, Vladlen Ivanushkin, Daniela Niepel, Katja Björklöf, Peter Černelč
Different CALR mutation subtypes in essential thrombocythemia and primary myelofibrosis patients without JAK2 mutation
Layla M. Saleh, Reem Algamal, Hanaa Abd Elmasseh, Emily Barber, Hasan Abdel-ghaffar
